Nonmyeloablative Allogeneic Stem-Cell Transplantation for Metastatic Renal Cell Cancer: A Review and Update

Metastatic renal cell carcinoma (RCC) is resistant to conventional chemotherapy and radiotherapy. However, immunotherapy appears to be effective in 15—20% of cases, with interleukin-2 becoming the standard therapy for this disease. As a consequence of the immune susceptibility of RCC, other avenues...

Descripción completa

Detalles Bibliográficos
Autores principales: Erotocritou, P., Ahmed, H., Patel, S.S., Shergill, I., Patel, H.R., Shah, P.M., Arya, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2006
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917236/
https://www.ncbi.nlm.nih.gov/pubmed/17619726
http://dx.doi.org/10.1100/tsw.2006.391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917236/
https://www.ncbi.nlm.nih.gov/pubmed/17619726
http://dx.doi.org/10.1100/tsw.2006.391

Ejemplares similares